Literature DB >> 3651930

Neuromyopathy associated with amodiaquine hydrochloride.

R Wittes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3651930      PMCID： PMC1267279     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  CHLOROQUINE NEUROMYOPATHY.

Authors:  J P WHISNANT; R E ESPINOSA; R R KIERLAND; E H LAMBERT
Journal:  Proc Staff Meet Mayo Clin       Date:  1963-11-06

2.  Chloroquine neuromyopathy.

Authors:  J A Hicklin
Journal:  Ann Phys Med       Date:  1968-02

3.  Letter: Neuromyopathy during malaria suppression with chloroquine.

Authors:  A Karstorp; H Ferngren; P Lundbergh; U Lying-Tunell
Journal:  Br Med J       Date:  1973-12-22

4.  Chloroquine neuromyopathy associated with keratopathy and retinopathy.

Authors:  A Erringer; P Colville
Journal:  Br Med J       Date:  1967-04-22

5.  Chloroquine myopathy.

Authors:  M J Eadie; T M Ferrier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-08       Impact factor: 10.154

6.  Motor polyneuroapthy and nystagmus associated with chloroquine phosphate.

Authors:  J S Marks
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

7.  Chloroquine neuromyopathy, a reversible granulovascuolar myopathy.

Authors:  H H Itabashi; E Kökmen
Journal:  Arch Pathol       Date:  1972-03

8.  Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

Authors:  C S Hatton; T E Peto; C Bunch; G Pasvol; S J Russell; C R Singer; G Edwards; P Winstanley
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

9.  PERIPHERAL NEUROPATHY FOLLOWING CHLOROQUINE THERAPY.

Authors:  L R LOFTUS
Journal:  Can Med Assoc J       Date:  1963-11-02       Impact factor: 8.262
  9 in total
  2 in total

1.  Adverse reactions to chloroquine and amodiaquine as used for malaria prophylaxis: a review of the literature.

Authors:  R Wittes
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

2.  In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax.

Authors:  Mikhail Martchenko Shilman; Gloria Bartolo; Saleem Alameh; Johnny W Peterson; William S Lawrence; Jennifer E Peel; Satheesh K Sivasubramani; David W C Beasley; Christopher K Cote; Samandra T Demons; Stephanie A Halasahoris; Lynda L Miller; Christopher P Klimko; Jennifer L Shoe; David P Fetterer; Ryan McComb; Chi-Lee C Ho; Kenneth A Bradley; Stella Hartmann; Luisa W Cheng; Marina Chugunova; Chiu-Yen Kao; Jennifer K Tran; Aram Derbedrossian; Leeor Zilbermintz; Emiene Amali-Adekwu; Anastasia Levitin; Joel West
Journal:  ACS Infect Dis       Date:  2021-07-04       Impact factor: 5.084
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.